Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-8-24
pubmed:abstractText
To investigate the effects of overproduction of IL-12p40, a potent antagonist against IL-12, on lupus-like autoimmune disease in vivo, we generated p40 transgenic MRL-Fas(lprcg)/Fas(lprcg) mice. Serum p40 and IL-12 levels were 600- to 8000-fold and 3- to 20-fold higher in transgenic (p40-lpr(cg)) than nontransgenic (lpr(cg)) mice, respectively. Serum IFN-gamma levels increased after 3 months of age in lpr(cg) and this age-related increase was completely abrogated in p40-lpr(cg). Serum IL-4 levels were the same in both mice. Production of IgM and IgG anti-double-stranded DNA (dsDNA) antibodies was significantly lower in p40-lpr(cg). Anti-dsDNA antibodies decreased in Th1-dependent IgG2a but increased in the Th2-dependent IgG1 subclass significantly in p40-lpr(cg). Proteinuria, glomerulonephritis, and survival were only marginally ameliorated in p40-lpr(cg). The results suggest that excess p40 production in vivo may suppress Th1 responses in autoantibody and IFN-gamma production but lead to minimal improvement of clinical manifestations of autoimmune disease in this mouse model.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0008-8749
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Academic Press.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
210
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
77-86
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11520074-Aging, pubmed-meshheading:11520074-Animals, pubmed-meshheading:11520074-Antibodies, Anti-Idiotypic, pubmed-meshheading:11520074-Antibodies, Antinuclear, pubmed-meshheading:11520074-Antibody Specificity, pubmed-meshheading:11520074-Antigens, CD95, pubmed-meshheading:11520074-Autoimmune Diseases, pubmed-meshheading:11520074-Crosses, Genetic, pubmed-meshheading:11520074-DNA, pubmed-meshheading:11520074-Dimerization, pubmed-meshheading:11520074-Disease Models, Animal, pubmed-meshheading:11520074-Female, pubmed-meshheading:11520074-Gene Therapy, pubmed-meshheading:11520074-Genes, Synthetic, pubmed-meshheading:11520074-Immunoglobulin G, pubmed-meshheading:11520074-Immunoglobulin M, pubmed-meshheading:11520074-Interferon-gamma, pubmed-meshheading:11520074-Interleukin-12, pubmed-meshheading:11520074-Interleukin-4, pubmed-meshheading:11520074-Kidney, pubmed-meshheading:11520074-Lupus Erythematosus, Systemic, pubmed-meshheading:11520074-Lupus Nephritis, pubmed-meshheading:11520074-Lymphoproliferative Disorders, pubmed-meshheading:11520074-Male, pubmed-meshheading:11520074-Mice, pubmed-meshheading:11520074-Mice, Inbred C57BL, pubmed-meshheading:11520074-Mice, Inbred MRL lpr, pubmed-meshheading:11520074-Mice, Transgenic, pubmed-meshheading:11520074-Protein Subunits, pubmed-meshheading:11520074-Proteinuria, pubmed-meshheading:11520074-Sex Factors, pubmed-meshheading:11520074-Th1 Cells, pubmed-meshheading:11520074-Th2 Cells, pubmed-meshheading:11520074-Transgenes
pubmed:year
2001
pubmed:articleTitle
Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
pubmed:affiliation
Laboratory Animal Research Center, University of Tokyo, Minato-ku, Tokyo, Japan. takuwa@med.toho-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't